Record #22995
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Journal
Publisher
Original paper date
Mar 18, 2020
Original DOI
Country
Institution
National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China · National Engineering Research Center for the Emergence Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China
Open access
No
Article type
Broad categories
Notes from Retraction Watch
Study appears to be back online:https://www.sciencedirect.com/science/article/pii/S2095809920300631?via%3Dihub
Citation lifecycle
How this paper is being cited
Pre-retraction
38
Same day
8
Post-retraction
1,151
% post-retraction
115.8%
~991.4 citations/yr before retraction · ~178.2 citations/yr after
— citing papers
Who is still citing this work
Loading…